MeiraGTx Holdings PLC (MGTX) - Total Liabilities
Based on the latest financial reports, MeiraGTx Holdings PLC (MGTX) has total liabilities worth $250.22 Million USD as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
MeiraGTx Holdings PLC - Total Liabilities Trend (2016–2025)
This chart illustrates how MeiraGTx Holdings PLC's total liabilities have evolved over time, based on quarterly financial data. See working capital position of MeiraGTx Holdings PLC to evaluate short-term liquidity relative to the company's equity base.
MeiraGTx Holdings PLC Competitors by Total Liabilities
The table below lists competitors of MeiraGTx Holdings PLC ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Vaudoise Assurances Holding SA
SW:VAHN
|
Switzerland | CHF6.34 Billion |
|
BlackRock Health Sciences Trust II
NYSE:BMEZ
|
USA | $6.03 Million |
|
Mishra Dhatu Nigam Limited
NSE:MIDHANI
|
India | Rs15.08 Billion |
|
Shanghai Xinpeng Industry Co Ltd
SHE:002328
|
China | CN¥1.82 Billion |
|
Xian Peri Power Semiconductor Cond
SHE:300831
|
China | CN¥61.50 Million |
|
Oppenheimer Holdings Inc
NYSE:OPY
|
USA | $2.90 Billion |
|
Changchun Zhiyuan New Energy Equipment Co. Ltd
SHE:300985
|
China | CN¥1.71 Billion |
|
China Petrochemical Development Corp
TW:1314
|
Taiwan | NT$51.81 Billion |
Liability Composition Analysis (2016–2025)
This chart breaks down MeiraGTx Holdings PLC's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see MeiraGTx Holdings PLC (MGTX) market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.75 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -43.19 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 1.02 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how MeiraGTx Holdings PLC's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for MeiraGTx Holdings PLC (2016–2025)
The table below shows the annual total liabilities of MeiraGTx Holdings PLC from 2016 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $250.22 Million | +23.92% |
| 2024-12-31 | $201.92 Million | +7.08% |
| 2023-12-31 | $188.57 Million | -5.95% |
| 2022-12-31 | $200.50 Million | +48.78% |
| 2021-12-31 | $134.76 Million | +7.69% |
| 2020-12-31 | $125.14 Million | -5.97% |
| 2019-12-31 | $133.09 Million | +740.44% |
| 2018-12-31 | $15.84 Million | -78.37% |
| 2017-12-31 | $73.22 Million | +84.48% |
| 2016-12-31 | $39.69 Million | -- |
About MeiraGTx Holdings PLC
MeiraGTx Holdings plc, a clinical-stage genetic medicines company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited retinal diseases and large degenerative ocular diseases; neurodegenerative diseases; and xerostomia. It is also develops AAV-AQP1 for radiation-induced grade 2/3 radiation-induced xe… Read more